Effectiveness of bleeding preventive powder for reducing postoperative PCNL complications

Effect of ARISTA Hemostatic Powder on Reduction of Complications after PCNL Surgery

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190624043991N2

Enrollment

Registered

2019-09-07

Start date

2019-09-06

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary stones. Calculus of kidney with calculus of ureter

Interventions

Intervention 1: Intervention group: Half of Patients undergoing PCNL surgery after the end of surgery and removal of stones and re-examination of the kidney with a nephroscope before removing the ampl

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Candidate for PCNL treatment

Exclusion criteria

Exclusion criteria: Patients with blood coagulation defects Patients with acute urinary tract infections Pregnant women Very obese people

Design outcomes

Primary

Measure	Time frame
Bleeding after surgery from the site of surgery. Timepoint: Immediately after surgery. Method of measurement: The number of wet gases.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzaneh Bagherpour

Tehran University of Medical Sciences

farzaneh.bagherpoor@yahoo.com+98 21 6634 8560

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026